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Distinct T Cell Subsets and Cytokine
Production in Cultures Derived from
Transformation Zone and Squamous
Intraepithelial Lesion Biopsies of the Uterine
Cervix
INTRODUCTION
Uterine cervix cancers represent good examples of
human malignant neoplasms preceded by well charac-
terized preneoplastic stages that are designated as
squamous intraepithelial lesions (SIL).1 SIL almost
exclusively develop in an area of metaplastic epithe-
lium located at the junction between the exo- and the
endo-cervix, the so-called transformation zone (TZ).2
Human papillomavirus (HPV) infection is the main
etiological agent of cervical cancer. However, HPV
infection is not sufﬁcient for cancer development and
the observation that these cancers are more frequent in
immunodeﬁcient women3,4 strongly suggests a role of
the immune system in the outcome of HPV infections
and associated (pre)cancerous lesions. Moreover, type
II (IL4/IL6) or immunosuppressive (IL10) cytokines
are preferentially found in the cervix5,6 and in the
peripheral blood7,8 of women with SIL. In addition,
the importance of activated lymphocyte inﬁltration in
the regression of HPV-associated genital warts has
been reported.9
Thus, a better characterization of the lymphocyte
populations present in the TZ region (where HPV
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PROBLEM: The characterization of lymphocytes issued from
squamous intraepithelial lesions (SIL) and from the transformation
zone (TZ), where the majority of SIL occur, is important to understand
the role of immunity in SIL development.
METHOD OF STUDY: We compared lymphocyte populations of
the TZ and SIL with those of normal exocervix, using a technique
allowing for the isolation of lymphocytes, either from the epithelium or
from the underlying stroma of small biopsies.
RESULTS: The majority of cells derived from the epithelium of all
biopsies were CD8+ T cells. Some SIL-derived cultures were
characterized by an increased proportion of activated TCRcd+. The
production of the immunosuppressive cytokine IL10 was signiﬁcantly
higher in lymphocyte cultures from the normal TZ in comparison with
the exocervix. A decreased percentage of effector T cells was observed
in cultures derived from the stroma of normal TZ (TCRcd+) or SIL
(CD8+) in comparison with the exocervix.
CONCLUSIONS: Our results suggest that a low proportion of
effector T cells and IL10 production could contribute to the
predisposition of the TZ to the development of SIL and to the
progression of SIL to cervical cancer.
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infection and SIL generally occur)2 and in preneoplas-
tic lesions is crucial to determine their implication in
the protection against HPV and the development of
SIL. Therefore, cervical biopsies were collected from
SIL-bearing patients or from cervical lesion-free
women. For each specimen, the SIL and the normal
TZ was compared with normal exocervix of the same
women. To further dissect the local immune mecha-
nisms, we analyzed lymphocytes from epithelial and
stromal tissues separately.10 For each sample, the
epithelium was detached from the underlying stroma
and both fragments were seeded in culture. This
technique allowed us to perform phenotypic and
functional studies including cytokine production of
isolated lymphocytes.
MATERIALS AND METHODS
Patients
Women with a cervical SIL diagnosed by cytology and
a colposcopically directed biopsy were recruited for
this study. For each patient, fresh biopsies (2–4 mm3)
of normal exocervix and SIL were obtained before any
surgical procedures. In addition, we also obtained
normal TZ and normal exocervix biopsies from women
undergoing hysterectomy for other reasons than cer-
vical pathology. These biopsies were carried out in
keratinocyte culture medium (DMEM/HAMs)11 con-
taining 100 U/mL gentamycin (Gibco, Merelbeke,
Belgium) and 1.5 lg/mL fungizone (Gibco) and proc-
essed within a few hours. HPV DNA was analyzed in
biopsy specimens by PCR with degenerated oligonu-
cleotides hybridizing in L1 open reading frame.12
HPV) biopsies of patients with normal cervix and
HPV+ SIL biopsies of patients with SIL were analyzed
in this work. For patients with SIL, some exocervix
biopsies were HPV+. This study protocol was ap-
proved by the Ethics Committee of the Faculty of
Medicine of the University of Lie`ge.
Cell Cultures
As shown in our previous studies,10 stromal lympho-
cytes were grown in culture medium supplemented
with IL2 alone, whereas epithelium-derived lympho-
cytes, which are rare in the tissue samples, had to be
cultured with IL2, in the presence of a feeder layer and
phytohemaglutinin (PHA).
Brieﬂy, the biopsies were incubated in dispase II
(2.4 U/mL) (Boehringer Mannheim, Brussels, Bel-
gium) at 37C, with the stroma side down, for 1 hr.
The epithelial sheet was then gently removed from the
stroma and both tissues were washed separately. The
culture medium consisted of RPMI 1640 (Gibco),
supplemented with 1% non-essential amino acids
(Gibco), sodium pyruvate (1 mM) (Gibco), 100 U/mL
penicillin-streptomycin (Gibco) and 1.5 lg/mL fungiz-
one (Gibco). The stromal fragments were placed in
96 U-bottom microwells (Nunclon, Nunc, Denmark)
with 200 lL of culture medium containing human
recombinant IL2 (50 U/mL, Biosource, Nivelles, Bel-
gium). Cells migrating out of the tissue were collected
every 2 days during the ﬁrst 2 weeks of culture. These
cells were maintained in culture with IL2 (50 U/mL)
and the medium was changed twice weekly. The
epithelial sheets were cultured for 2 days in
U-bottom microwells with 200 lL of culture medium
containing IL2 (50 U/mL). On day 2, the cells were
dissociated by agitation, and depending on the size and
quality of the biopsy, 2000–30,000 cells were placed in
200 lL of culture medium containing IL2 (50 U/mL),
PHA (0.1%) and 105 autologous irradiated peripheral
blood mononuclear cells (PBMC). PBMC were
obtained from 10 mL of heparinized blood, prepared
by centrifugation on Lymphoprep gradients (Nycomed,
Oslo, Norway) and washed three times in culture
medium before irradiation, using an X-ray apparatus
(Stabilivolt Siemens Berlin, Germany) (190 KV, 18
mA, HVL: 0.5 mm CU, focal distance: 35 cm) at a
dose rate of 1.4 Gy/min (total irradiation: 30 Gy).
Fresh medium containing only IL2 (50 U/mL) was
added to the epithelium-derived cell cultures twice
weekly. The origin (exocervix, TZ and SIL) of the
epithelium was conﬁrmed by Papanicolaou-stained
cytospins of epithelial sheet after 2 days of culture, as
previously described.10
Flow Cytometry Analysis
Double- and triple-staining were performed with
ﬂuorescent conjugated antibodies. The following
monoclonal antibodies were used: anti-CD3 (SK7,
PerCP), CD4 (SK3, FITC), CD8 (SK1, PerCP), CD16
(NKP15, FITC), CD19 (4G7, FITC), CD56 (MY31,
PE) and TCRd (11F2, FITC) (BD Biosciences, Erem-
bodegem, Belgium), CD25 (M-A251, PE), anti-integrin
b7 (FIB504, PE) (Pharmingen, San Diego, CA, USA),
CD103 (2G5, FITC) and HLA-DR (FITC) (Immuno-
tech, Marseille, France). The phenotype was per-
formed on 1 · 105–5 · 105 cells following standard
protocols. The cells were analyzed for ﬂuorescence
intensity on a FACScan with CellQuest software (BD
Biosciences).
Immunohistochemical Staining
Eight-micrometer frozen sections were ﬁxed in 2%
paraformaldehyde (UCB, Louvain, Belgium). Endog-
enous peroxidase was blocked with 0.2% H2O2 in
phosphate buffered saline PBS for 30 min. The slides
were then incubated overnight at 4C with monoclonal
antibodies speciﬁc for CD3 (SK7), CD8 (SK1) (BD
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Biosciences San Diego, CA, USA) and TCRcd (B1)
(Pharmingen) or isotype controls in PBS with BSA
(2%) and NaN3 (0.1%). Biotin-labeled secondary
antibodies (1/100 biotin-goat antimouse IgG)
(Vector, Burlingame, USA) (1/100 biotin-goat antirat)
(Pharmingen) were applied for 30 min at room tem-
perature. The slides were then incubated with avidin–
biotin–HRP complex (Vectastain, ABC-HRP kit;
Vector) for 30 min Diaminobenzidine (0.5 mg/mL)
(Sigma, Bomem Belgium) was used as chromogen.
Slides were counter-stained with hematoxylin and
mounted for light microscopy.
Enzyme linked immunosorbent assay (ELISA)
assays IL-4 and IL-10 cytokines were measured by
using speciﬁc immunoassays from Pharmingen (Bel-
gium). For IFN-c enzyme linked immunosorbent assay
ELISA assay, antibodies from Serpine (Lattulpe Bel-
gium) were used. Recombinant human IL-4, IL-10 and
IFN-c were used as reference standards.
Statistical Analysis
The non-parametric Mann–Whitney or ANOVA test
was applied, using Prism 2.0a software (GraphPad
Software, San Diego, CA, USA).
RESULTS
Increased Proportion of TCRcd and Activated Cells
(CD25+) in Some Cultures Derived from SIL
Epithelium
After 20–30 days of culture, 2 · 106–100 · 106 cells
were obtained for biopsy. These numbers were similar
for all types of biopsies (normal exocervix, normal TZ
or SIL biopsies) (data not shown). The cell phenotype
is summarized in Table I. In all cultures (exocervix, TZ
and SIL), more than 50% of the cells were CD8+ T
cells. Few NK cells and no B cells (CD19+) were
detected. Nearly all T cells expressed the memory
marker CD45R0 (Table I). We found less than 10% of
lymphocytes expressing the activation marker CD25
(IL2 receptor) in most cases of exocervix (5/19
cultures) and TZ (8/10 cultures) cultures, whereas
more than 30% of cells were positive for CD25 in 7/9
SIL- derived cultures (P < 0.05) (Table I). Usually
less than 10% of the cells expressed the TCRcd, but
interestingly, in 3/5 high-grade SIL cultures, more than
40% expressed this receptor (Table I). A large portion
of these cells showed an activated phenotype (CD25+)
(data not shown).
To conﬁrm the epithelial origin of the T lympho-
cytes, we analyzed the expression of the aE(103)b7
integrin, which is preferentially expressed on intraepi-
thelial lymphocytes.13,14 In the cultures derived from
the epithelium, around 15% of cells expressed this
integrin, whereas less than 2% of positive cells were
detected in PBMC of the same patient (Fig. 1).
TABLE I. Phenotype of Lymphocytes Derived from the Epithelium
Exon
a TZa Exos
b SILb
T cells (CD3+) 95 ± 2 (17)c 93 ± 3 (17) 87 ± 6,10 95 ± 3 (10)
T helper cells (CD4+) 19 ± 5 (17) 23 ± 6 (17) 22 ± 8 (10) 16 ± 8 (10)
T cytotoxic cells (CD8+) 74 ± 6 (15) 67 ± 7 (15) 61 ± 8 (10) 64 ± 8 (10)
TCR cd T cells 5 ± 2 (15) 7 ± 3 (15) 2 ± 2 (11) 24 ± 12 (11)
NK cells (CD3–CD56+) 5 ± 3 (14) 5 ± 3 (14) 12 ± 6 (10) 3 ± 2 (10)
B cells (CD19+) < 1 < 1 < 1 < 1
CD45R0+ cells > 95 > 95 > 95 > 95
CD25+ cells 6 ± 4 (10) 10 ± 6 (10) 16 ± 6 (9) 34 ± 8 (9)
aExon and TZ ¼ normal exocervix and transformation zone biopsies of patients with normal cervix.
bExos and SIL ¼ normal exocervix and SIL biopsies of patients with SIL.
cMeans of cell percentage ± S.E. of total cells after 20–30 days of culture (n) are represented.
Fig. 1. Expression of the aE(CD103)b7 integrin. Facs analysis of
lymphocytes from exocervix epithelium derived culture (Exo) and on
PBMC of the same patient with anti-b7 PE and anti-CD103 FITC
mAb.
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Increased IL10 Production in Lymphocyte Cultures
Derived from the TZ Epithelium
To investigate which type of cytokine is produced by T
lymphocytes, levels of IL10 (immunosuppressive cyto-
kine), IL4 (type II cytokine) and IFN-c (type I
cytokine) were analyzed in the culture supernatants
by ELISA (Fig. 2). Interestingly, a signiﬁcantly higher
production of IL10 was observed in cultures of
lymphocytes derived from the TZ in comparison with
the exocervix (P < 0.05). No major diﬀerences were
observed in IL10 and IL4 levels between exocervix and
SIL. In patients with SIL, a high amount of IL10 was
detected in cultures derived from exocervix HPV+
(Fig. 2). IFN-c, which is often produced in response to
viral infection, was the only cytokine signiﬁcantly
expressed in cultures derived from SIL, suggesting that
the production of IFN-c could reﬂect a response
against HPV in some patients (Fig. 2).
Decreased Proportion of Eﬀector T Cells in Cultures
Derived from the Stroma of TZ and SIL
To develop a model as close as possible to the in vivo
situation, lymphocytes derived from the stroma were
obtained in the presence of IL2 alone (without
addition of PHA and autologous PBMC). Between
0.1 · 106 and 5 · 106 lymphocytes were obtained after
20–30 days of culture. The number of lymphocytes
generated in cultures was similar in all types of biopsies
(normal exocervix, normal TZ or SIL biopsies). After
20–30 days of culture, a lower percentage of T cells
was obtained in stromal cultures from TZ (P < 0.05)
and SIL (P < 0.01), as compared with paired normal
exocervix (Fig. 3A). Most CD3- cells were CD56+ NK
cells (Fig. 3A). The percentage of CD4+ T cells did not
decrease in TZ and SIL, as compared with exocervix
cultures (Table II). However, the percentage of T cells
with a cytotoxic potential, such as CD8+ T cells and
TCRcd+ cells, was lower in SIL cultures (TCRcd+
cells, P < 0.01) and in TZ cultures (CD8+ T cells,
P < 0.01) than in exocervix-derived cultures (Fig. 3B).
Interestingly, patients with a high percentage of
TCRcd+ cells in the epithelium-derived cultures also
showed a high percentage of these cells in the stroma-
derived cultures.
To evaluate the number of CD8+ and TCRcd+ cells
in vivo, immunohistochemical staining was performed
on frozen biopsies. Very few TCRcd+ T cells were
detected in all biopsies tested (exocervix, TZ and SIL)
(data not shown). In agreement with the results
obtained in vitro, a signiﬁcantly lower number of
CD8+ T cells were observed in the SIL underlying
stroma, compared with the normal exocervix
(P < 0.05) (Fig. 3C). The diﬀerence between exocer-
vix and TZ was not signiﬁcant. In parallel with FACS
results, we also observed a decreased number of CD3+
T cells in SIL versus normal exocervix, whereas the
number of CD4+ T cells was similar in both tissues
(data not shown).
Higher IFN-c Production in Cultures Derived
from the Stroma of Patients with SIL
Cytokines were also analyzed in lymphocyte cultures
derived from the stroma in the presence of IL2 alone
(Fig. 4). The results were more heterogeneous than
Fig. 2. Cytokine production in cultures of lymphocytes derived from the epithelium. The cytokine production was evaluated by ELISA assays
and the results were reported for 1 · 106 cells. Each empty circle represents a biopsy HPV) and each full circle represents a biopsy HPV+. Exon
and TZ ¼ normal exocervix and transformation zone biopsies of patients with normal cervix; Exos and SIL ¼ normal exocervix and SIL
biopsies of patients with SIL; ND ¼ undetermined, *P < 0.05.
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those observed in cultures derived from the epithelium.
No signiﬁcant diﬀerence was detected between the
exocervix versus TZ, or between the exocervix versus
SIL cultures. However, an increased production of
IFN-c was observed in patients with SIL, in compar-
ison with patients with normal cervix (Fig. 4).
DISCUSSION
The diﬀerent immune microenvironments that we
found in cervical mucosa are as follows: a higher
production of the immunosuppressive cytokine IL10 in
the epithelium of the TZ, a higher proportion of
TCRcd+ cells in some SIL and a lower number of T
cells in the stroma underlying SIL or TZ. These
differences might have important consequences for the
immune response decision against HPV infection and
tumor development.
To the best of our knowledge, this is the ﬁrst study
analyzing the phenotype and functional characteristics
of lymphocytes isolated either from preneoplastic
lesions or from the underlying stroma. Interesting
results had already been obtained with whole cervical
biopsies.15,16 To further expand these studies, we
sought to discriminate the contribution of lymphocytes
derived from the epithelium and from the stroma,
because lymphocytes derived from whole biopsies have
a mixed origin. A great majority of cells are likely to
derive from the stroma since connective tissue usually
constitutes the major part of the biopsies. Moreover,
the density of lymphocytes is higher in the stroma,
compared with the epithelium. Much attention has
also been paid in this study to compare SIL with the
normal exocervix and the TZ, where most cervical SIL
and cancers develop.2
The majority of lymphocytes issued from the
epithelium of all biopsies were CD8+ T cells, which
is in agreement with a previous in situ study.17 The
epithelial origin of these lymphocytes is supported by
the expression of the aE(CD103)b7 integrin, which has
been described as a marker of intraepithelial lympho-
cytes.13,14,18 Moreover, the CD103 antigen has been
recently described on a discrete and stable subset of
human cytotoxic CD8+ cells.19 An increased number
of cytotoxic cells detected in situ was previously
reported during cervical tumor progression.20 As
TCRcd+ T cells could also display cytotoxic functions
against virus infected cells21 and skin cancer22, we also
analyzed this population and demonstrated an
increased percentage of these cells in high-grade SIL.
The presence of TCRcd+ T cells in cervical carci-
noma,23 in genital warts infected by HPV624 or in mice
grafted with syngeneic keratinocyte expressing
HPV1625 has been previously reported. Follow-up
Fig. 3. Phenotype of lymphocytes derived from the stroma.
(A) Exom and TZ ¼ normal exocervix and transformation zone
paired biopsies of patients with normal cervix; Exos and
SIL ¼ normal exocervix and SIL paired biopsies of patients
with SIL. (B) CD8+ and TCRc+ T lymphocytes in the stroma.
Means ± S.E. after 20–30 days of culture are represented, *P <
0.05, **P < 0.01. (C) In situ CD8 immunostaining. Means ±
S.E. are represented, *P < 0.05.
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studies are needed to determine if the presence of
TCRcd+ T cells is correlated with tumor protection or
lesional relapse prevention. Only some CD56+ NK
cells were observed in epithelium-derived cultures. This
is in agreement with the study of Mc Kenzie and
collaborators, showing that NK cells are usually
localized in the stroma underlying SIL.26
We previously showed by RT–PCR that TZ and SIL
are associated with an increased IL10 expression.6
Moreover, several studies have also reported the
presence of abnormal cytokine production in cervico-
vaginal washings using RT-PCR or Elisa assays
without determining the cytokine producing cells.27
Interestingly, in this study we showed that T lympho-
cytes from the TZ epithelium-derived cultures pro-
duced high levels of IL10, suggesting that these cells
are responsible, at least partially, for the IL10 secretion
in the TZ. We did not observe an increased IL10
production in cultures derived from SIL, suggesting
that this cytokine is produced by tumoral keratino-
cytes, as already reported.28
Although generally described as an immunosuppres-
sive cytokine,29–32 IL10 has been recently shown to
enhance the cytotoxic potential of HPV-speciﬁc T cells,
suggesting that this cytokine could help the immune
response already established against HPV-infected
keratinocytes. However, in this study, we found high
levels of IL10 in the TZ before HPV infection.
Furthermore, the negative effects of IL10 on antigen-
presenting cells and on the induction of immune
response have been demonstrated.32,33 The presence
of IL10 could be linked to the lower number of
antigen-presenting cells observed in TZ.34 Moreover,
this IL10 production could negatively interfere with
the induction of a type I immune response, which has
been shown to be associated with a subsequent
clearance of cervical HPV infection.27 Several hypo-
theses have been proposed to explain the increased
sensitivity of cervical TZ to HPV infection and cancer
development.35,36 Hence, a particular immune mic-
roenvironment could take place in the TZ and confer
an increased sensitivity to HPV infection and tumor
Fig. 4. Cytokine production in cultures of lymphocytes derived from the stroma. The cytokine production was evaluated by ELISA assays and
the results were reported for 1 · 106 cells. Each empty circle represents a biopsy HPV– and each full circle represents a biopsy HPV+. Exon and
TZ ¼ normal exocervix and transformation zone biopsies of patients with normal cervix; Exos and SIL ¼ normal exocervix and SIL biopsies of
patients with SIL; ND ¼ not determined.
TABLE II. Phenotype of Lymphocytes Derived from the Stroma
Exon
a TZa Exos
b SILb
CD16+ CD3– cells 6 ± 6 (5)c 4 ± 3 (5) 5 ± 5 (5) 3 ± 1 (3)
CD4+ T cells 19 ± 5 (18) 14 ± 5 (18) 14 ± 5 (17) 22 ± 5 (17)
CD45R0+ cells > 95 > 95 > 95 > 95
CD25+ cells 25 ± 6 (13) 26 ± 8 (9) 31 ± 5 (7) 52 ± 4 (10)
aExon and TZ ¼ normal exocervix and transformation zone biopsies of patients with normal cervix.
bExos and SIL ¼ normal exocervix and SIL biopsies of patients with SIL.
cMeans of cell percentage ±S.E. after 20–30 days of culture (n) are represented.
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development. The high production of the immunosup-
pressive cytokine IL10 that we observed in T lympho-
cyte cultures derived from this region is in clear
agreement with this hypothesis.
We also analyzed the lymphocyte populations
derived from the stroma underlying the SIL and TZ.
In these cultures, the lymphocyte phenotype was more
diversiﬁed. The proportion of NK cells was more
important in TZ and SIL stroma-derived cultures, as
previously reported in SIL by an in situ study.26 In
parallel, the percentage of T cells was lower in TZ and
SIL stroma, compared with the exocervix. Interest-
ingly, within T cells, the populations of cytotoxic
lymphocytes were found to be under-represented in
SIL (CD8+ and TCRcd+) and in TZ (TCRcd+)
stroma-derived cultures. Because in a bovine model,
only CD8+ and TCRcd+ lymphocytes were able to
migrate into papilloma fronds,37 our results suggested
the presence of a cellular immune defect in the SIL and
TZ stroma. The lower proportion of CD8+ T cells
and/or TCRcd+ cells in cultures derived from SIL or
TZ stroma could be due to a lower number of these
cells in situ and/or to a proliferative defect in response
to IL2. However, using immunohistochemistry, we
found a quantitative reduction of CD8+ T cells in the
stroma adjacent to the SIL. Very few TCRcd+ T cells
were detected in the stroma, which is consistent with a
previous study.23 The difﬁculty of detecting TCRcd+
T cells in situ underlines the necessity to expand this
important cell population by a culture method for
analysis.
Despite the immune alterations described above, an
immune response could take place in some patients
leading to the elimination of HPV infection. As IFN-c
production is induced in response to viral infection, the
higher IFN-c levels in some patients with SIL could
reﬂect an immune response against HPV. Accordingly,
high amounts of IFN-c transcripts were associated
with a good prognosis.38 Similarly, the high proportion
of TCRcd cells expressing IL2 receptor (CD25) in
some SIL-derived cultures could also be linked to the
presence of an immune response against HPV.
In conclusion, our results suggest that quantitative
and qualitative alterations of local T lymphocyte
populations have important consequences for the
development of a protective immune response in the
uterine cervix. Similarities between TZ and SIL lym-
phocyte populations suggest that the immune altera-
tions observed in SIL cultures are related both to
modiﬁcations caused by HPV infections or associated
lesions and to the particular phenotype of lymphocytes
inﬁltrating the TZ. Studies are under investigation to
better understand the role of the diﬀerent lymphocyte
populations in response to HPV antigens.
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